Acquisition

CVS Group plc 10 January 2008 For Immediate Release 10 January 2008 CVS Group plc ('CVS' or 'the Group') Acquisition of Axiom Veterinary Laboratories ('Axiom Lab') - Doubles Group Revenues in Diagnostic Laboratory Services CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of Axiom Lab. Founded in 1980, Axiom Lab provides diagnostic laboratory services to third party veterinary practices. CVS' existing three diagnostic laboratories specialise in histology and represented 7% of Group turnover in the year ended 30 June 2007. Axiom Lab complements the Group's diagnostic operations by bringing a strength and specialisation in biochemistry, as well as allergy testing, to its range of services. It will also double Group revenues derived from laboratory services. Management accounts for the year ended 31 December 2007 show that Axiom Lab achieved EBITDA of approximately £700,000 on turnover of approximately £4.5 million. The £4.039m consideration is being satisfied wholly in cash. Axiom Lab employs 10 vets across three sites and the team will remain with CVS after acquisition. We are pleased that owner, Peter Webb, will remain full time with the business as Managing Director of Axiom Lab. Commenting on the acquisition, CVS Chief Executive Simon Innes said 'Axiom Lab's biochemistry specialisation provides the perfect complement to our existing diagnostic services. We welcome the Axiom Lab team to CVS and look forward to the benefits of their considerable reputation in their specialist field.' Contacts: CVS Group plc 01379 644 288 Simon Innes, Chief Executive Paul Coxon, Finance Director Buchanan Communications 0207 466 5000 Richard Oldworth Suzanne Brocks This information is provided by RNS The company news service from the London Stock Exchange

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings